VVOS Vivos Therapeutics, Inc.
0.1510USD-1.76%Mkt Cap: 5.08M $P/E: —1d ago
Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), …
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap5.08M USD
Enterprise Value14.76M USD
Revenue (TTM)20.90M USD
Gross Profit10.54M USD
Net Income (TTM)-21.23M USD
Revenue/Share1.50 USD
Last Price0.1510 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees268
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.19
PEG—
EV/EBITDA-0.71
EV/Revenue0.71
P/S0.25
P/B-0.45
EPS (TTM)-1.88
EPS (Forward)-0.82
52W Range
0.12891% of range3.580
52W High3.580 USD
52W Low0.1289 USD
Profitability
Gross Margin60.44%
Oper. Margin-93.64%
EBITDA Margin-99.33%
Profit Margin-121.71%
ROE1424.83%
ROA-84.41%
Growth
Revenue Growth34.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.26M USD
CapEx (TTM)2.34M USD
FCF Margin-40.83%
FCF Yield-168.16%
Net Debt10.73M USD
Net Debt/EBITDA-0.52
Balance Sheet
Debt/Equity-9.06
Current Ratio0.21
Quick Ratio0.16
Book Value/Sh-0.34 USD
Cash/Share0.09 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateOct 27, 2023
Analyst Consensus
Rating—
Target (Mean)2.117 USD
Upside (mean)+1301.8%
Target Range0.7500 USD – 3.100 USD
0.7500+1301.8% to mean3.100
# Analysts3
Ownership
Shares Out.33.61M
Float19.10M
Insiders11.32%
Institutions3.90%
Short Interest
Short Ratio0.1d
Short % Float5.27%
Short % Out.4.84%
Shares Short1.63M
Short (prev mo.)1.25M
Technical
SMA 500.2463 (-38.7%)
SMA 2000.9313 (-83.8%)
Beta6.07
S&P 52W Chg16.45%
Avg Vol (30d)6.72M
Avg Vol (10d)8.72M
Technical Indicators
RSI (14)33.2
MACD-0.0324
MACD Signal-0.0407
MACD Hist.+0.0083
BB Upper0.1903 USD
BB Middle0.1595 USD
BB Lower0.1287 USD
BB Width38.60%
ATR (14)0.0199 USD
Vol Ratio (20d)0.05x